AI Article Synopsis
- * Out of 12 enrolled patients, most had FLT3 (58%) or CBL (42%) mutations; the treatment was found to be safe, as no maximum tolerated dose was reached and 83% had a positive response.
- * Common severe side effects included low platelet counts and infections, with patients showing a median overall survival of 17.5 months and FLT3 mutation clearance in 57% of cases, indicating promising results for this treatment approach.
Article Abstract
We conducted a phase 1 study evaluating 3 dose levels of quizartinib (30 mg, 40 mg or 60 mg) in combination with azacitidine for HMA-naïve or relapsed/refractory MDS or MDS/MPN with FLT3 or CBL mutations. Overall, 12 patients (HMA naïve: n=9, HMA failure: n=3) were enrolled; 7 (58 %) patients had FLT3 mutations and 5 (42 %) had CBL mutations. The maximum tolerated dose was not reached. Most common grade 3-4 treatment-emergent adverse events were thrombocytopenia (n=5, 42 %), anemia (n=4, 33 %), lung infection (n=2, 17 %), skin infection (n=2, 17 %), hyponatremia (n=2, 17 %) and sepsis (n=2, 17 %). The overall response rate was 83 % with median relapse-free and overall survivals of 15.1 months (95 % CI 0.0-38.4 months) and 17.5 months (95 % CI NC-NC), respectively. FLT3 mutation clearance was observed in 57 % (n=4) patients. These data suggest quizartinib is safe and shows encouraging activity in FLT3-mutated MDS and MDS/MPN. This study is registered at Clinicaltrials.gov as NCT04493138.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.leukres.2024.107518 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Density Functional Theory (DFT) Modeling Study of NO Reduction by CO over Graphene-Supported Single-Atom Ni Catalysts in the Presence of CO, SO, O, and HO.
Langmuir
January 2025
Centre for Energy (M473), The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.
The mechanisms of NO reduction by CO over nitrogen-doped graphene (N-graphene)-supported single-atom Ni catalysts in the presence of O, HO, CO, and SO have been studied via density functional theory (DFT) modeling. The catalyst is represented by a single Ni atom bonded to four N atoms on N-graphene. Several alternative reaction pathways, including adsorption of NO on the Ni site, direct reduction of NO by CO, decomposition of NO to NO followed by reduction of NO to N, formation of active oxygen radical O*, and reduction of O* by CO, were hypothesized and the energy barrier corresponding to each of the reaction steps was calculated using DFT.
View Article and Find Full Text PDFMulti-Emitting Ratiometric Temperature Sensing and Tunable White Light Emitting Based on Effective Energy Transfer in a Lanthanide-Brønsted Acidic Ionic Liquid Coordination Polymer.
Inorg Chem
January 2025
Department of Chemistry, Department of Physics, Beijing Technology and Business University, Beijing 100048, China.
Isostructured lanthanide-Brønsted acidic ionic liquid coordination polymers, {[Ln(CHNO)(HO)]Cl} (LnIMDC(HO), Ln = Eu, Gd, or Tb, CHNO = [IMDC]) and {[EuTb(CHNO)(HO)]Cl} (EuTbIMDC(HO))), have been synthesized using 1,3-bis(carboxymethyl) imidazolium chloride ([HIMDC]Cl) as linkers. LnIMDC(HO) (Ln = Eu or Tb) and EuTbIMDC(HO) exhibit good temperature sensing performance over a wide temperature range with maximum sensitivities of 2.73%·K (392 K) and 2.
View Article and Find Full Text PDFEfficacy of bortezomib combined with Hyper-CVAD in adults with relapsed acute lymphoblastic leukemia or positive measurable residual disease; effect of bortezomib in leukemia.
Blood Res
January 2025
Hematology Laboratory, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City, Mexico.
Purpose: Despite advances in the treatment of adult acute lymphoblastic leukemia (ALL), relapse remains the most significant challenge in improving prognosis. Measurable residual disease (MRD) assessment can predict bone marrow relapse based on MRD positivity. As access to innovative therapies remains limited because of the high cost, chemotherapy is the widely utilized treatment option.
View Article and Find Full Text PDFBackground: Pediatric ultrasound (US)-guided percutaneous liver biopsy is a commonly performed procedure in children, and may be performed in a variety of clinical settings. However, there is little research on the relative costs associated with different sedation methods and locations.
Objective: This study uses time-driven activity-based costing (TDABC) to identify relevant costs associated with different biopsy sedation techniques and locations to help inform providers and patients as well as guide value-conscious care.
Associated diseases and their effects on disease course in patients with chronic non-bacterial osteomyelitis: retrospective experience from a single center.
Clin Rheumatol
January 2025
Division of Pediatric Rheumatology and Nephrology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Turkey.
Objective: Chronic non-bacterial osteomyelitis (CNO) is a rare autoinflammatory bone disease associated with other chronic inflammatory diseases such as familial Mediterranean fever (FMF), juvenile idiopathic arthritis (JIA), spondylarthropathies, inflammatory bowel disease (IBD), and pyoderma gangrenosum. We aimed to describe the clinical and follow-up characteristics of patients with CNO and to compare findings between patients with and without comorbidities.
Methods: The clinical records of patients with CNO who were followed up in our pediatric rheumatology clinic between 2018 and 2023 were reviewed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!